PTEN and neoplasm: Our restrictive criteria to only call a PTEN deletion if fewer PTEN signals than centromere 10 signals occur in ≥ 60% of tumor cells are based on the assumption that a clinically relevant heterogeneity will not occur within a tumor area of 0.6 mm in diameter.